Hepatic resection in the treatment of perihilar cholangiocarcinoma

Surgical Oncology Clinics of North America

Volumn 11, Issue 4, 2002, Pages 893-908

  Sarmiento, Juan M ^a   Nagorney, David M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; CANCER SURGERY; HISTOPATHOLOGY; HUMAN; LIVER RESECTION; OUTCOMES RESEARCH; PATIENT SELECTION; PREOPERATIVE EVALUATION; REVIEW; SURVIVAL RATE;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; PORTAL VEIN; TREATMENT OUTCOME;

EID: 0036812475     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(02)00034-0     Document Type: Review

References (64)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin 1998;48:6-29.
2. Altmeier WA, Gall ED, Zinninger MM, Hoxworth PL. Sclerosing carcinoma of the major intrahepatic bile ducts. Arch Surg 1959;75:450-61.
3. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatitis: An unusual tumor with distinctive clinical and pathological features. Am J Med 1965;38:241-56.
4. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 1996;224:463-73.
5. DeGroen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341:1368-78.
6. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983;139:217-38.
7. Balaton AJ, Nehama-Sibony M, Gotheil C, Callard P, Baviera EE. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. J Pathol 1988;156:305-10.
8. Hayashi S, Miyazaki M, Kondo Y, Nakajima N. Invasive growth patterns of hepatic hilar ductal carcinoma. Cancer 1994;73:2922-9.
9. Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: A histologic analysis of 62 resected cases. Ann Surg 1998;227:405-11.
10. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-5.
11. Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: A population-based study. Scand J Gastroenterol 1997;32:1042-5.
12. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-5.
13. Burke EC, Jarnagin WR, Hochwald SN, Pisters PWT, Fong Y, Blumgart LH. Hilar cholangiocarcinoma: Patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-94.
14. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodriewicz BSJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-17.
15. Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, et al. Lymph node metastasis from hilar cholangiocarcinoma audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 2001;233:385-92.
16. Nimura Y, Haykawa N, Kamiya J, Kondo S, Nagino M, Kanai M. Hilar cholangiocarcinoma-surgical anatomy and curative resection. J Hepatobiliary Pancreat Surg 1995;2:239-48.
17. Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, et al. Perihilar cholangiocarcinoma: Postoperative radiotherapy does not increase survival. Ann Surg 1995;221:788-97.
18. Buskirk SJ, Gunderson LL, Adson MA, Martinez A, May GR, McIlrath DC, et al. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1984;10:2013-23.
19. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-8.
20. Gallinger S, Gluckman D, Langer B. Proximal bile duct cancer. Adv Surg 1990;23:89-118.
21. Mulholland MW, Yahanda A, Yeo CJ. Multidisciplinary management of perihilar bile duct cancer. J Am Coll Surg 2001;193:440-7.
22. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M, Miyachi M, et al. Preoperative management of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1995;2:215-23.
23. Bach AM, Hann LE, Brown KT, Getrajdman GI, Herman SK, Fong Y, et al. Portal vein evaluation with US: Comparison to angiography combined with CT arterial portography. Radiology 1996;201:149-54.
24. Freeny PC. Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma. Ann Oncol 1999;10:12-7.
25. Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT. Cholangiocarcinoma: Spectrum of appearance on MR images using current techniques. Magn Reson Imaging 1998;16:993-1003.
26. Hochwald SN, Burke EC, Jarnagin WR, Fong Y, Blumgart LH. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999;134:261-6.
27. Miyagawa S, Makuuchi M, Kawasaki S. Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer. Arch Surg 1995;130:759-63.
28. Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000;7:155-62.
29. Abdalla EK, Hicks ME, Vauthey J-N. Portal vein embolization: Rationale, technique and future prospects. Br J Surg 2001;88:165-75.
30. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 1990;107:521-7.
31. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, et al. Preoperative portal vein embolization: An audit of 84 patients. Hepatology 1999;29:1099-105.
32. Kawasaki S, Makuuchi M, Miyagawa S, Kakazu T. Radical operation after portal embolization for tumor of the hilar bile duct. J Am Coll Surg 1994;178:480-6.
33. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995;117:677-81.
34. Nimura Y, Kamiya J, Kondo S. Technique of inserting multiple biliary drains and management. Hepato-Gastroenterol 1995;45:323-31.
35. Chapman WC, Sharp KW, Weaver F, Sawyers JL. Tumor seeding from percutaneous biliary catheters. Ann Surg 1989;209:708-15.
36. Jarnagin WR, Bodniewicz J, Dougherty E, Conlon K, Blumgart LH, Fong Y. A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg 2000;4:34-43.
37. Hadjis NS, Blenkharn JI, Alexander N, Benjamin IS, Blumgart LH. Outcome of radical surgery in hilar cholangiocarcinoma. Surgery 1990;107:597-604.
38. Nimura Y, Hayakawa N, Kamiya J, Maeda S, Kondo S, Yasui A, et al. Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg 1991;78:727-31.
39. Farnell MB, Nagorney DM. Technique for resection of extrahepatic cholangiocarcinoma. In: Donohue JH, van Heerden JA, Monson JRT, editors. Atlas of Surgical Oncology. Cambridge, MA: Blackwell Science; 1995, p. 204-12.
40. Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990;159:91-7.
41. Gerhards MF, van Gulik TM, de Wit LT, Obertop H, Gouma DJ. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma - A single center experience. Surgery 2000;127:395-404.
42. Tabata M, Kawarada Y, Yokoi H, Higashiguchi T, Isaji S. Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2000;7:148-54.
43. Gazzaniga GM, Ciferri E, Bagarolo C, Filauro M, Bondanza G, Fazio S, et al. Primitive hepatic hilum neoplasm. J Surg Oncol 1993;3:140-6.
44. Gazzaniga GM, Filauro M, Bagarolo C, Mori L. Surgery for hilar cholangiocarcinoma: An Italian experience. J Hepatobiliary Pancreat Surg 2000;7:122-7.
45. Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, et al. Management of hilar cholangiocarcinoma: Comparison of an American and a Japanese experience. Ann Surg 2000;232:166-74.
46. Kawarada Y, Suzuki H, Mizumoto R. Surgical treatment of hilar carcinoma of the bile duct, with special reference to anatomy of the hepatic hilum and caudate lobe. Jpn J Gastroenterol Surg 1984;17:1684-8.
47. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990;4:1990.
48. Ogura Y, Mizumoto R, Tabata M, Matsuda S, Kusuda T. Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg 1993;17:85-92.
49. Sugiura Y, Nakamura S, Iisda S, Hosoda Y, Ikeuchi S, Mori S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: A cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 1994;115:445-51.
50. Launois B, Reding R, Lebeau G, Bauard JL. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg 2000;7:128-34.
51. Farley DR, Weaver AL, Nagorney DM. "Natural history" of unresected cholangiocarcinoma: Patient outcome after noncurative intervention. Mayo Clin Proc 1995;70:425-9.
52. Lee SG, Lee YJ, Park KM, Hwang S, Min PC. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg 2000;7:135-41.
53. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808-18.
54. Flickinger JC, Epstein AH, Iwatsuki S, Carr BI, Starzl TE. Radiation therapy for primary carcinoma of the extrahepatic biliary system: An analysis of 63 cases. Cancer 1991;68:289-94.
55. Foo ML, Gunderson LL, Bender DE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1997;39:929-35.
56. Kuvshinoff BW, Armstrong JG, Fong Y, Schupak K, Getradjman G, Heffernan N, et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995;82:1522-5.
57. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 1994;28:945-51.
58. Hejna M, Pruckmayer M, Raderer M, The role of chemotherapy and radiation in the management of biliary cancer: A review of the literature. Eur J Cancer 1998;34:977-86.
59. Verbeek PC, Van Leeuwen DJ, Van DerHeyde MN, Gonzalez Gonzalez D. Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients, Ann Chir 1991;45:350-4.
60. Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, et al. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Rad Oncol Biol Phys 2000;46:581-7.
61. Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: A multivariate analysis of prognostic factors. J Clin Oncol 1997;15:947-54.
62. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999;230:663-71.
63. Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Shimizu Y, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: Hepatic or local resection? Surgery 1998;123:131-6.
64. Su C-H, Tsay S-H, Wu C-C, Shyr YM, King KL, Lee CH, et al. P'eng FK: Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996;223:384-94.